Activity of five fluoroquinolones against Mycobacterium avium-intracellulare complex and M. xenopi.

Suppr

超能文献

作者信息

Rastogi N, Goh K S, David H L

机构信息

Unité de la Tuberculose et des Mycobactéries, Institut Pasteur, Paris.

出版信息

Ann Inst Pasteur Microbiol. 1988 Mar-Apr;139(2):233-7. doi: 10.1016/0769-2609(88)90008-7.

DOI:10.1016/0769-2609(88)90008-7

PMID:3165641

Abstract

摘要

相似文献

Activity of five fluoroquinolones against Mycobacterium avium-intracellulare complex and M. xenopi.

Ann Inst Pasteur Microbiol. 1988 Mar-Apr;139(2):233-7. doi: 10.1016/0769-2609(88)90008-7.

Comparative in-vitro activity of five fluoroquinolones against mycobacteria.

J Antimicrob Chemother. 1987 May;19(5):605-9. doi: 10.1093/jac/19.5.605.

In vitro activity of four fluoroquinolones against eighty-six isolates of mycobacteria.

Eur J Clin Microbiol. 1987 Oct;6(5):584-6. doi: 10.1007/BF02014255.

[Sensitivity of 7 mycobacterial species to new quinolones].

Pathol Biol (Paris). 1988 May;36(5):477-81.

[In vitro activity of ciprofloxacin and ofloxacin against Mycobacterium tuberculosis, M. avium, M. africanum, M. kansasii and BCG strains].

Immun Infekt. 1986 Nov;14(6):203-7.

In vitro activity of five new quinolones against cultivable mycobacteria.

Eur J Clin Microbiol. 1987 Oct;6(5):572-3. doi: 10.1007/BF02014249.

Comparative in vitro activity of amifloxacin and five other fluoroquinolone antimicrobial agents and preliminary criteria for the disk susceptibility test.

Eur J Clin Microbiol. 1987 Apr;6(2):179-82. doi: 10.1007/BF02018204.

In vitro susceptibility of aerobic gram-negative blood culture isolates to oxolinic acid, norfloxacin, ciprofloxacin, enoxacin, pefloxacin, ofloxacin and oxo-enoxacin.

Infection. 1986 May-Jun;14(3):142-4. doi: 10.1007/BF01643481.

Comparative in vitro activities of ciprofloxacin, enoxacin, norfloxacin, ofloxacin and pefloxacin against Bacteroides fragilis and Clostridium difficile.

Scand J Infect Dis. 1986;18(2):149-51. doi: 10.3109/00365548609032321.

Comparative in vitro activities of pefloxacin, ofloxacin, enoxacin and ciprofloxacin against 256 clinical isolates.

Acta Pathol Microbiol Immunol Scand B. 1987 Apr;95(2):141-6. doi: 10.1111/j.1699-0463.1987.tb03102.x.

引用本文的文献

Mycobacteria and the new quinolones.

Antimicrob Agents Chemother. 1989 Jan;33(1):1-5. doi: 10.1128/AAC.33.1.1.

MICs and MBCs of Win 57273 against Mycobacterium avium and M. tuberculosis.

Antimicrob Agents Chemother. 1990 May;34(5):770-4. doi: 10.1128/AAC.34.5.770.

In vitro activity of the new difluorinated quinolone sparfloxacin (AT-4140) against Mycobacterium tuberculosis compared with activities of ofloxacin and ciprofloxacin.

Antimicrob Agents Chemother. 1991 Sep;35(9):1933-6. doi: 10.1128/AAC.35.9.1933.

Extracellular and intracellular activities of clarithromycin used alone and in association with ethambutol and rifampin against Mycobacterium avium complex.

Antimicrob Agents Chemother. 1991 Mar;35(3):462-70. doi: 10.1128/AAC.35.3.462.

Antimycobacterial spectrum of sparfloxacin and its activities alone and in association with other drugs against Mycobacterium avium complex growing extracellularly and intracellularly in murine and human macrophages.

Antimicrob Agents Chemother. 1991 Dec;35(12):2473-80. doi: 10.1128/AAC.35.12.2473.

Emergence during unsuccessful chemotherapy of multiple drug resistance in a strain of Mycobacterium tuberculosis.

Eur J Clin Microbiol Infect Dis. 1992 Oct;11(10):901-7. doi: 10.1007/BF01962370.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验